Evidence map›Paper›PMID 35744988›Full record

ArticleMolecules (Basel, Switzerland)2022

Eszter Csikós, Kata Csekő, Ágnes Kemény, Lilla Draskóczi, László Kereskai, Béla Kocsis, Andrea Böszörményi, Zsuzsanna Helyes, Györgyi Horváth

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. An Update on the Therapeutic Anticancer Potential ofMolecules (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Eszter CsikósDepartment of Pharmacognosy, Faculty of Pharmacy, University of Pecs, H-7624 Pecs, Hungary.
Kata CsekőDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pecs, H-7624 Pecs, Hungary.
Ágnes KeményDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pecs, H-7624 Pecs, Hungary.
Lilla DraskócziDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pecs, H-7624 Pecs, Hungary.
László KereskaiDepartment of Pathology, Medical School, University of Pecs, H-7624 Pecs, Hungary.
Béla KocsisDepartment of Medical Microbiology and Immunology, Medical School, University of Pecs, H-7624 Pecs, Hungary.
Andrea BöszörményiInstitute of Pharmacognosy, Faculty of Pharmacy, Semmelweis University, H-1085 Budapest, Hungary.
Zsuzsanna HelyesDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pecs, H-7624 Pecs, Hungary.
Györgyi HorváthDepartment of Pharmacognosy, Faculty of Pharmacy, University of Pecs, H-7624 Pecs, Hungary.ORCID 0000-0001-5344-0294
University of Pecs · HUSemmelweis University · HU

Funding

NEW NATIONAL EXCELLENCE PROGRAM OF THE MINISTRY FOR INNOVATION AND TECH-NOLOGY FROM THE SOURCE OF THE NATIONAL RESEARCH, DEVELOPMENT AND INNOVATION FUND ÚNKP-20-3-IITématerületi Kiválósági Program, Hungary TKP2021-EGA-13Tématerületi Kiválósági Program, Hungary TKP2021-EGA-21
6 · The paper itself

Abstract

Scots pine (SO) and clove (CO) essential oils (EOs) are commonly used by inhalation, and their main components are shown to reduce inflammatory mediator production. The aim of our research was to investigate the chemical composition of commercially available SO and CO by gas chromatography-mass spectrometry and study their effects on airway functions and inflammation in an acute pneumonitis mouse model. Inflammation was evoked by intratracheal endotoxin and EOs were inhaled three times during the 24 h experimental period. Respiratory function was analyzed by unrestrained whole-body plethysmography, lung inflammation by semiquantitative histopathological scoring, myeloperoxidase (MPO) activity and cytokine measurements. α-Pinene (39.4%) was the main component in SO, and eugenol (88.6%) in CO. Both SO and CO significantly reduced airway hyperresponsiveness, and prevented peak expiratory flow, tidal volume increases and perivascular edema formation. Meanwhile, inflammatory cell infiltration was not remarkably affected. In contrast, MPO activity and several inflammatory cytokines (IL-1β, KC, MCP-1, MIP-2, TNF-α) were aggravated by both EOs. This is the first evidence that SO and CO inhalation improve airway function, but enhance certain inflammatory parameters. These results suggest that these EOs should be used with caution in cases of inflammation-associated respiratory diseases.

Indexed as

AsthmaOils, VolatilePinus sylvestrisPneumoniaSyzygiumAnimalsEndotoxinsInflammationMiceEndotoxinsOils, Volatileairway hyperresponsivenessairway inflammationclovecytokineendotoxinessential oilmouse modelmyeloperoxidase activityperivascular edemaScots pine

Identifiers

PMID35744988
PMCPMC9229653
OpenAlexW4283075874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.